title: Association of the OGG1-Ser326Cys polymorphism with lung adenocarcinoma risk.
abstract: Adenocarcinoma (ADC) is the most frequent histological type of lung cancer and comprises the majority of lung cancers in non-smokers. Thus, genetic factors responsible for ADC susceptibility need to be determined to establish efficient ways of preventing the disease. The OGG1 gene, encoding a glycosylase for 8-hydroxyguanine, an oxidatively damaged promutagenic base, has the polymorphism Ser326Cys, and OGG1-326Cys protein was indicated to have a lower ability to prevent mutagenesis than the OGG1-326Ser protein. Case-control studies to date suggest that the OGG1-326Cys allele is associated with a higher risk for several types of cancers, including overall lung cancer. However, the contribution of this polymorphism to lung ADC risk is unclear. In the present study, the OGG1-Ser326Cys polymorphism was assessed for association with lung ADC risk using a case-control study of a Japanese population consisting of 1097 cases and 394 controls. Odds ratios (OR) of the 326Cys allele carriers increased in a dose-dependent manner with allele number (P for the trend test = 0.04). The OR of homozygotes for the 326Cys allele was increased significantly when homozygotes for the 326Ser allele were used as a reference (OR = 1.5, 95% confidence interval [CI] = 1.0-2.1, P = 0.04). Furthermore, the overall OR for lung ADC of the Cys/Cys homozygotes out of a total of 1925 ADC patients and 3449 controls from six case-control studies reported up to the present were 1.43 (95% CI = 1.11-1.84, P = 0.0045). These results indicate that OGG1-326Cys functions as a risk allele for lung ADC development.
authors.affiliation: Biology Division, National Cancer Center Research Institute, Chuo-ku, Tokyo 104-0045.
authors.forename: Takashi
authors.initials: T
authors.lastname: Kohno
authors.forename: Hideo
authors.initials: H
authors.lastname: Kunitoh
authors.forename: Kaoru
authors.initials: K
authors.lastname: Toyama
authors.forename: Seiichiro
authors.initials: S
authors.lastname: Yamamoto
authors.forename: Aya
authors.initials: A
authors.lastname: Kuchiba
authors.forename: Daizo
authors.initials: D
authors.lastname: Saito
authors.forename: Noriko
authors.initials: N
authors.lastname: Yanagitani
authors.forename: Shin-ichi
authors.initials: S
authors.lastname: Ishihara
authors.forename: Ryusei
authors.initials: R
authors.lastname: Saito
authors.forename: Jun
authors.initials: J
authors.lastname: Yokota
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics*; D000368:Aged; D000483:Alleles; D000595:Amino Acid Sequence / Q000235:genetics; D016022:Case-Control Studies; D045647:DNA Glycosylases / Q000235:genetics*; D005260:Female; D018628:Gene Dosage; D020022:Genetic Predisposition to Disease; D006801:Humans; D007564:Japan; D008175:Lung Neoplasms / Q000235:genetics*; D008875:Middle Aged; D011110:Polymorphism, Genetic; D012306:Risk
chemical_list: D045647:DNA Glycosylases; C479058:oxoguanine glycosylase 1, human